ED Syphilis/HIV/HCV Screening

Transforming Addiction Treatment Through 24/7 Access in Emergency Departments

Click here for more details.

To help with your drug use.

​​Emergency Departments are uniquely positioned to identify people with undiagnosed syphilis, HIV, and hepatitis C virus infections.

From 2023-2026, the California Department of Public Health (CDPH) partnered with the Public Health Institute’s Bridge Center to expand routine opt-out testing for syphilis, HIV, and hepatitis C virus (HCV) infection through the Emergency Department Syphilis/HIV/HCV Screening Program (EDSP).

EDSP increased public health equity and provided immediate care for people at highest chance for sexually transmitted infections, HIV, and HCV. EDs are uniquely positioned to reach those who might otherwise remain undiagnosed and reduce care barriers. ED screening helps control these growing epidemics statewide.

The EDSP model was proven statewide across a diversity of EDs in both rural and urban settings, with 96% of sites funded and supported by the CDPH/Bridge program reporting plans to continue screening post-funding, and 57% permanently sustaining their program navigators. This successful EDSP model includes a person-centered syndemic approach based on values of human dignity, trauma-informed racial and social justice, and harm reduction in the promotion of health equity.

View our 2023-2026 Impact

Los Angeles County ED Screening Program

Building on these successes, Bridge is expanding routine opt-out screening for HIV and syphilis infection through partnership with the Los Angeles County Department of Public Health’s Division of HIV and STD Programs (DHSP).  The LA Emergency Department Screening Program (LA EDSP) funds and supports emergency departments from 2025-2027.

LA EDSP’s goal is to increase routine opt-out testing for syphilis and HIV in emergency departments in Los Angeles County, especially increasing access to treatment and linkage to care for communities experiencing homelessness and/or a high burden of syphilis/congenital syphilis.

Sexually transmitted infections have reached an all-time high in the U.S. and California

Syphilis

Syphilis has re-emerged as a significant public health concern in California. The state has witnessed a concerning rise in syphilis cases over recent years, with certain populations, such as men who have sex with men, pregnant women, and racial and ethnic minorities, being disproportionately affected. Untreated syphilis can result in severe health complications, including neurological disorders, cardiovascular issues, and even death. Moreover, congenital syphilis, a preventable condition in which the infection is passed from mother to child during pregnancy, has also seen a resurgence, highlighting the urgent need for timely detection and intervention. 

HIV

The need for increased HIV testing in California is crucial to addressing the ongoing public health challenge posed by the HIV epidemic. Despite significant advancements in HIV prevention and treatment, the state continues to report a high number of new HIV diagnoses each year, with certain populations disproportionately affected. Expanding access to HIV testing is a key strategy to identify undiagnosed individuals, enabling them to receive life-saving treatment and support while simultaneously reducing the transmission of the virus. Additionally, increased testing is essential in raising awareness about HIV risk and fostering a culture of prevention. 

Hepatitis C

Hepatitis C virus (HCV) infection, caused by a blood-borne virus primarily affecting the liver, can lead to serious health complications, including cirrhosis, liver cancer, and liver failure. Many individuals infected with HCV remain unaware of their status due to the asymptomatic nature of the infection during its early stages. Expanding access to HCV testing will identify those affected, linking them to appropriate treatment and care and ultimately preventing long-term health consequences. Increased testing can also help reduce the transmission of the virus by promoting awareness and encouraging safer practices.

LA EDSP Awardee Information

The Los Angeles County Department of Public Health’s Division of HIV and STD Programs (DHSP) is partnering with the Public Health Institute’s Bridge Center (PHI/Bridge) to expand routine opt-out screening for HIV and syphilis infection in LA County through the LA Emergency Department Screening Program (LA EDSP).

Hospitals funded under LA EDSP will be expected to establish or sustain emergency department (ED) routine opt-out screening programs and provide patient education and navigator-led linkage to follow-up care, including treatment as appropriate. This includes taking a syndemic approach based on the values of human dignity, intersectional and trauma-informed racial and social justice, and harm reduction in the promotion of health equity and person-centered care. The program especially seeks to increase access to treatment and linkage to care for communities experiencing homelessness and/or a high burden of syphilis and congenital syphilis. 

LA EDSP 2025-2027 Awardees:

The following awarded hospitals are eligible to receive up to $200,000 in the First Term (June 1, 2025 – February 28, 2026), and up to $100,000 in the Second Term (March 1, 2026 – February 28, 2027). 

  • East Los Angeles Doctors Hospital
  • Memorial Hospital of Gardena
  • Coast Plaza Hospital

LA EDSP 2026-2027 Awardee: 

The following awarded hospital is eligible to receive up to up to $165,000 in the 2026/27 Term (March 1, 2026 – February 28, 2027).

  • Community Hospital of Huntington Park

Awardee Technical Assistance Webinars

Webinar attendance by the EDSP Clinical Champion & Patient Navigator(s) meets a program participation requirement of the contract.

We’ll share future webinar dates soon—please revisit for details.

Statewide Awardee Information

From 2023-2026, The CA Department of Public Health and Bridge awarded $13,125,000 in funds to 28 hospital emergency departments in fourteen counties across the state to implement, expand, or sustain a routine opt-out syphilis, HIV, and hepatitis C virus (HCV) infection screening program, and provide patient navigation linkage to treatment and prevention. The awardees represent a diversity of high-volume, mid-volume, and low-volume EDs in urban and rural areas.

Statewide CDPH ED Screening Program 2023-2026

Statewide Awardee Information

From 2023-2026, The CA Department of Public Health and Bridge awarded $13,125,000 in funds to 28 hospital emergency departments in fourteen counties across the state to implement, expand, or sustain a routine opt-out syphilis, HIV, and hepatitis C virus (HCV) infection screening program, and provide patient navigation linkage to treatment and prevention. The awardees represent a diversity of high-volume, mid-volume, and low-volume EDs in urban and rural areas.

LA County ED Screening Program 2025-2027

LA EDSP Awardee Information

The Los Angeles County Department of Public Health’s Division of HIV and STD Programs (DHSP) is partnering with the Public Health Institute’s Bridge Center (PHI/Bridge) to expand routine opt-out screening for HIV and syphilis infection in LA County through the LA Emergency Department Screening Program (LA EDSP).

Hospitals funded under LA EDSP will be expected to establish or sustain emergency department (ED) routine opt-out screening programs and provide patient education and navigator-led linkage to follow-up care, including treatment as appropriate. This includes taking a syndemic approach based on the values of human dignity, intersectional and trauma-informed racial and social justice, and harm reduction in the promotion of health equity and person-centered care. The program especially seeks to increase access to treatment and linkage to care for communities experiencing homelessness and/or a high burden of syphilis and congenital syphilis. 

LA EDSP 2025-2027 Awardees:

The following awarded hospitals are eligible to receive up to $200,000 in the First Term (June 1, 2025 – February 28, 2026), and up to $100,000 in the Second Term (March 1, 2026 – February 28, 2027). 

  • East Los Angeles Doctors Hospital
  • Memorial Hospital of Gardena
  • Coast Plaza Hospital

LA EDSP 2026-2027 Awardee: 

The following awarded hospital is eligible to receive up to up to $165,000 in the 2026/27 Term (March 1, 2026 – February 28, 2027).

  • Community Hospital of Huntington Park

Awardee Technical Assistance Webinars

Webinar attendance by the EDSP Clinical Champion & Patient Navigator(s) meets a program participation requirement of the contract.

We’ll share future webinar dates soon—please revisit for details.

Emergency Department resources for screening, prevention, treatment, and linkage to care for syphilis, HIV, and hepatitis C.

Featured Resource: ED Guide to PEP, PrEP, and STI Prevention

Bridge’s ED Syphilis/HIV/HCV Screening Program is proud to release our latest novel clinical protocol, the ED Guide to PEP, PrEP, and STI Prevention!

Developed in partnership with the California Department of Public Health, this evidence-based pathway revolutionizes access to care in the emergency department, empowering providers to promptly address and prevent bacterial STIs and HIV to improve patient outcomes.

ED Guide to PEP, PrEP, and STI Prevention

Emergency Department Screening and Treatment Protocols

Patient Education Handouts for Linkage to Care

These customizeable resources are also available in simplified Chinese, traditional Chinese, Spanish, Tagalog, and Vietnamese.

More Resources

Bridge EDSP Key Implementation Resources

Additional Resources

Monthly Peer-to-Peer Community of Practice

CDPH Sexually Transmitted Diseases (STD) Control Branch facilitates a monthly Screening for Syphilis, HIV, and HCV in ED Settings, Community of Practice to foster discussions among EDs on best practices, barriers and solutions, including partnering with Local Health Departments on patient navigation and linkage to care.

To join, please contact us at EDSP@bridgetotreatment.org.

Contact Emergency Department Syphilis/HIV/HCV Screening Program

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Our work is made possible through the support of our past and current funders: